Literature DB >> 24591894

Claudin and ovarian cancer.

Chinmoy K Bose1, Ashis Mukhopadhyay1.   

Abstract

Claudins are a family of proteins and the most important component of the tight junction. They constitute a paracellular barrier that controls the flow of molecules in the intercellular space of an epithelium. Although it seems that claudin should be down regulated in cancer cell, some claudins are, in fact highly elevated in various human cancers, including ovarian cancer. Whereas the functional significance of claudin overexpression in ovarian carcinoma is unclear, these proteins are important for migration, invasion, and survival of ovarian cancer cells. They clearly represent a general pathway in tumorigenesis, are a novel marker for ovarian cancer and may become a target for therapy or diagnosis of this disease.

Entities:  

Keywords:  Clostridium perfringens enterotoxin; Tight junction; claudin; occludin; ovarian cancer

Year:  2010        PMID: 24591894      PMCID: PMC3939305     

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  56 in total

1.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

2.  Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.

Authors:  Benoit Terris; Ekaterina Blaveri; Tatjana Crnogorac-Jurcevic; Melanie Jones; Edoardo Missiaglia; Philippe Ruszniewski; Alain Sauvanet; Nicholas R Lemoine
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer.

Authors:  F Krämer; K White; M Kubbies; K Swisshelm; B H Weber
Journal:  Hum Genet       Date:  2000-09       Impact factor: 4.132

4.  Potential markers that complement expression of CA125 in epithelial ovarian cancer.

Authors:  Daniel G Rosen; Lin Wang; J Neeley Atkinson; Yinhua Yu; Karen H Lu; Eleftherios P Diamandis; Ingegerd Hellstrom; Samuel C Mok; Jinsong Liu; Robert C Bast
Journal:  Gynecol Oncol       Date:  2005-08-02       Impact factor: 5.482

5.  Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression.

Authors:  Leticia B A Rangel; Cheryl A Sherman-Baust; Roman P Wernyj; Donald R Schwartz; Kathleen R Cho; Patrice J Morin
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

6.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

7.  Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.

Authors:  Lilach Kleinberg; Arild Holth; Claes G Trope; Reuven Reich; Ben Davidson
Journal:  Hum Pathol       Date:  2008-05       Impact factor: 3.466

8.  Tight junction formation in epithelial ovarian adenocarcinoma.

Authors:  Yihong Zhu; Karin Sundfeldt
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

9.  Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

Authors:  Y-L Choi; J Kim; M J Kwon; J S Choi; T-J Kim; D-S Bae; S S Koh; Y-H In; Y W Park; S H Kim; G Ahn; Y K Shin
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

10.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Agnes Szik; Csilla Páska; Pál Kaposi Novák; László Szilák; András Kiss; Krisztina Bögi; Zsuzsa Schaff
Journal:  Breast Cancer Res       Date:  2005-01-31       Impact factor: 6.466

View more
  2 in total

1.  Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4.

Authors:  Songhui Zhou; Ruicheng Wang; Hong Xiao
Journal:  Oncol Rep       Date:  2020-06-16       Impact factor: 3.906

2.  Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family.

Authors:  Peipei Gao; Ting Peng; Canhui Cao; Shitong Lin; Ping Wu; Xiaoyuan Huang; Juncheng Wei; Ling Xi; Qin Yang; Peng Wu
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.